Literature DB >> 20439967

Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children.

María Cecilia Albareda1, Gabriela Carina Olivera, Ana María De Rissio, Miriam Postan.   

Abstract

We previously reported that the T cell compartment in chronically Trypanosoma cruzi-infected adult subjects display functional and phenotypic signs of immune senescence. This study aimed to investigate the differentiation and the senescent profile of the overall CD8(+) T cell compartment in T. cruzi-infected children at the early stage of the disease. We found a lower percentage of naive (CD27(+)CD28(+)CD45RA(+)) and early antigen-experienced (CD45RA(-)CD27(+)CD28(+)), and higher percentages of late differentiated antigen-experienced (CD45RA(-)CD27(-)CD28(-)) CD8(+) T cells in T. cruzi-infected children as compared with age-matched uninfected controls. The expression of the interleukin (IL)-7R is also decreased on naive and on antigen-experienced total CD8(+) T cells with various degrees of differentiation. Conversely, the expression of HLA-DR, caspase-3, and CD57 did not vary on the total CD8(+) T cell compartment. These findings suggest that the duration of the infection is relevant in the process of immune senescent that this parasite can induce.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439967      PMCID: PMC2861381          DOI: 10.4269/ajtmh.2010.09-0604

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

1.  Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease.

Authors:  S A Laucella; E L Segura; A Riarte; E S Sosa
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern.

Authors:  Renato Sathler-Avelar; Danielle Marquete Vitelli-Avelar; Rodrigo Lima Massara; Marta de Lana; João Carlos Pinto Dias; Andréa Teixeira-Carvalho; Silvana Maria Elói-Santos; Olindo Assis Martins-Filho
Journal:  Microbes Infect       Date:  2007-10-22       Impact factor: 2.700

3.  Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.

Authors:  R Sathler-Avelar; D M Vitelli-Avelar; R L Massara; J D Borges; M Lana; A Teixeira-Carvalho; J C P Dias; S M Elói-Santos; O A Martins-Filho
Journal:  Scand J Immunol       Date:  2006-11       Impact factor: 3.487

4.  Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.

Authors:  Rodolfo Viotti; Carlos Vigliano; Bruno Lococo; Graciela Bertocchi; Marcos Petti; María Gabriela Alvarez; Miriam Postan; Alejandro Armenti
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

5.  Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.

Authors:  A L de Andrade; F Zicker; R M de Oliveira; S Almeida Silva; A Luquetti; L R Travassos; I C Almeida; S S de Andrade; J G de Andrade; C M Martelli
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

6.  Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease.

Authors:  Susana A Laucella; Miriam Postan; Diana Martin; Bolyn Hubby Fralish; Maria C Albareda; Maria G Alvarez; Bruno Lococo; Gustavo Barbieri; Rodolfo J Viotti; Rick L Tarleton
Journal:  J Infect Dis       Date:  2004-02-17       Impact factor: 5.226

7.  Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.

Authors:  Alexandre Harari; G Paolo Rizzardi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Daniel Kaufmann; Amalio Telenti; Roland Sahli; Giuseppe Tambussi; Laurent Kaiser; Adriano Lazzarin; Luc Perrin; Giuseppe Pantaleo
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 8.  Immune system recognition of Trypanosoma cruzi.

Authors:  Rick L Tarleton
Journal:  Curr Opin Immunol       Date:  2007-07-24       Impact factor: 7.486

9.  Altered representation of naive and memory CD8 T cell subsets in HIV-infected children.

Authors:  R L Rabin; M Roederer; Y Maldonado; A Petru; L A Herzenberg; L A Herzenberg
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.

Authors:  Elisabeth Amyes; Chris Hatton; Damien Montamat-Sicotte; Nancy Gudgeon; Alan B Rickinson; Andrew J McMichael; Margaret F C Callan
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  10 in total

1.  Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.

Authors:  M Cecilia Albareda; Damián Perez-Mazliah; M Ailén Natale; Melisa Castro-Eiro; María G Alvarez; Rodolfo Viotti; Graciela Bertocchi; Bruno Lococo; Rick L Tarleton; Susana A Laucella
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

2.  Dysfunctional adaptive immunity during parasitic infections.

Authors:  Ryan A Zander; Noah S Butler
Journal:  Curr Immunol Rev       Date:  2013-08-01

3.  Alteration of T Cell Subtypes in Beta-Thalassaemia Major: Impact of Ferritin Level.

Authors:  Batoul Pourgheysari; Leila Karimi; Pezhman Beshkar
Journal:  J Clin Diagn Res       Date:  2016-02-01

4.  Low IL-2 Expressing T Cells in Thalassemia Major Patients: Is It Immune Aging.

Authors:  Batoul Pourgheysari; Leila Karimi; Raihaneh Bagheri; Soleiman Kheiri
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-07       Impact factor: 0.900

5.  Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas Disease.

Authors:  Nisha Jain Garg; Kizhake V Soman; Maria P Zago; Sue-Jie Koo; Heidi Spratt; Susan Stafford; Zinzi N Blell; Shivali Gupta; Julio Nuñez Burgos; Natalia Barrientos; Allan R Brasier; John E Wiktorowicz
Journal:  PLoS Negl Trop Dis       Date:  2016-02-26

Review 6.  Cellular Stress and Senescence Induction during Trypanosoma cruzi Infection.

Authors:  Kamila Guimarães-Pinto; Jesuíno R M Ferreira; André L A da Costa; Alexandre Morrot; Leonardo Freire-de-Lima; Debora Decote-Ricardo; Celio Geraldo Freire-de-Lima; Alessandra A Filardy
Journal:  Trop Med Infect Dis       Date:  2022-07-11

7.  T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.

Authors:  Nicolás A Giraldo; Natalia I Bolaños; Adriana Cuellar; Nubia Roa; Zulma Cucunubá; Fernando Rosas; Víctor Velasco; Concepción J Puerta; John M González
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31

8.  Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults.

Authors:  María C Albareda; Ana M De Rissio; Gonzalo Tomas; Alicia Serjan; María G Alvarez; Rodolfo Viotti; Laura E Fichera; Mónica I Esteva; Daniel Potente; Alejandro Armenti; Rick L Tarleton; Susana A Laucella
Journal:  PLoS Negl Trop Dis       Date:  2013-12-12

9.  Trypanosoma cruzi Infection Induces Cellular Stress Response and Senescence-Like Phenotype in Murine Fibroblasts.

Authors:  Kamila Guimarães-Pinto; Danielle Oliveira Nascimento; Antonia Corrêa-Ferreira; Alexandre Morrot; Celio G Freire-de-Lima; Marcela F Lopes; George A DosReis; Alessandra A Filardy
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

10.  Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes.

Authors:  María C Albareda; María A Natale; Ana M De Rissio; Marisa Fernandez; Alicia Serjan; María G Alvarez; Gretchen Cooley; Huifeng Shen; Rodolfo Viotti; Jacqueline Bua; Melisa D Castro Eiro; Myriam Nuñez; Laura E Fichera; Bruno Lococo; Karenina Scollo; Rick L Tarleton; Susana A Laucella
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.